SYNCOR EARNINGS JUMP 64%.Byline: Ben Sullivan Daily News Staff Writer WOODLAND HILLS - Nuclear medicine specialist Syncor International on Monday reported a jump in fourth-quarter earnings led by improved sales of its radiopharmaceutical radiopharmaceutical /ra·dio·phar·ma·ceu·ti·cal/ (-fahr?mah-soo´ti-k'l) a radioactive pharmaceutical, nuclide, or other chemical used for diagnostic or therapeutic purposes. products. For the quarter ended Dec. 31, Syncor earnings rose 64 percent to $1.7 million, or 16 cents per diluted share, compared to $200,000 (1 cent) in 1996. The company's sales rose 4.3 percent for the quarter to $94.8 million, up from $90.9 million. For the year, Syncor earned $11.1 million ($1.08), a 45 percent gain over 1996 when it earned $4.6 million (44 cents) for the year. Syncor had annual sales of $380.6 million, a 3.9 percent increase over the $366.4 million it took in in 1996. Syncor makes and manufactures radioactive materials radioactive material Radiation A substance that contains unstable–radioactive–atoms that give off radiation as they decay. See Radioactive decay. used in medical imaging. Last year, the company entered the $60 billion medical imaging services market through a joint venture to establish 10 magnetic resonance imaging magnetic resonance imaging (MRI), noninvasive diagnostic technique that uses nuclear magnetic resonance to produce cross-sectional images of organs and other internal body structures. centers across the country, and in January bought the medical imaging businesses of TME See Tivoli Systems Management Software. Inc. and National Diagnostic Services diagnostic services, n.pl the imaging and laboratory capabilities available for determining the cause of an illness. Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion